The global fish oil market is anticipated to witness robust growth, increasing from USD 10.4 billion in 2025 to USD 24.6 billion by 2035, with a projected CAGR of 9.0% over the forecast period. This momentum is largely fueled by the expanding recognition of omega-3 fatty acids’ role in supporting heart, brain, and joint health, alongside growing usage in pharmaceutical formulations, dietary supplements, functional foods, pet nutrition, and aquaculture.
Key Industry Attributes
| Attribute | Detail |
|---|---|
| Market Size (2025) | USD 10.4 billion |
| Market Size (2035) | USD 24.6 billion |
| CAGR (2025-2035) | 9.0% |
Fish oil, rich in EPA and DHA, has become a cornerstone in the wellness economy. With increasing global health awareness, the demand for omega-3-rich formulations has surged across age groups. Advances in molecular distillation and ultra-purification technologies are enabling manufacturers to deliver higher quality and potency, particularly for pharmaceutical-grade and infant nutrition applications.
The fish oil market is projected to reach significant value growth by 2025 driven by rising demand for omega-3 fatty acids in dietary supplements, clinical nutrition, and pharmaceutical applications. Within the omega-3 ingredients market, fish oil holds a dominant 65-70% share, as it remains the most concentrated and bioavailable source of EPA and DHA.
In the nutraceutical ingredients market, it accounts for around 6-8%, supporting heart, brain, and joint health products. Within the functional food and beverage ingredients market, fish oil contributes about 2-3%, primarily through fortified beverages and dairy alternatives. It also holds 4-5% share in the animal feed additives market, especially in aquaculture and pet nutrition.
Salmon oil is expected to dominate the product type segment with a 45% market share in 2025, while refined fish oil will lead the processing category with a 40% share due to its purity and application in nutraceuticals and infant formulas. Omega Protein Corporation holds a 15% market share. Players like Colpex International are gaining traction with pharmaceutical-grade innovations. China, the USA, and Norway are key markets, with China growing fastest.
In a 2025 interview with NutraIngredients, Dr. Enrico Bachis, Market Research Director at IFFO, shared an encouraging update: “The fish meal and fish oil market is driven by supply. With good forecasts for 2025, we can be positive about the availability of fish oil for the nutraceutical sector.” He noted the impact of Peru’s record production surge in early 2025, which helped stabilize pricing and improve accessibility for both human and animal health application.
The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and current year (2025) for the global industry. This analysis reveals crucial shifts in market performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 (2024 to 2034) | 8.7% |
| H2 (2024 to 2034) | 9.3% |
| H1 (2025 to 2035) | 8.9% |
| H2 (2025 to 2035) | 9.5% |
The global industry's predicted compound annual growth rate (CAGR) over a semi-annual period from 2025 to 2035 is shown in the above table. The business is anticipated to grow at a CAGR of 8.7% in the first half (H1) of 2024 and then slightly faster at 9.3% in the second half (H2) of the same year.
The CAGR is anticipated to decrease somewhat to 8.9% in the first half of 2025 and continues to grow at 9.5% in the second half. The industry saw a decline of 35 basis points in the first half (H1 2025) and an increase of 46 basis points in the second half (H2 2025).
The fish oil market is projected to expand steadily, with salmon oil leading the product type segment (45% market share) and dietary supplements(38% market share) driving the demand in 2025, particularly in applications aimed at heart health, cognitive function, and general well-being.
Salmon oil is set to dominate the fish oil market, holding a 45% share in 2025.
Refined fish oil is expected to account for 40% of the fish oil market share by 2025.
Dietary supplements are expected to dominate the fish oil market by 2025, capturing 38% of the market share.
Feed-grade fish oil is gaining prominence within the fish oil market due to its vital role in the aquaculture sector capturing 15% of the market share.
Pharmaceutical-Grade Omega-3 Dominance
The medical applications of high-concentration omega-3 fish oils are shifting the supply chains primarily turmeric fish oils, which is rising as a consequence. Prescription omega-3-based drugs such as Vascepa® and Lovaza® are commonly used for the treatment of cardiovascular diseases, high triglyceride levels, and inflammatory disorders.
To optimize the EPA and DHA content while adhering to the pharmaceutical industry's tough regulations, the companies are investing in ultra-purification processes. Transition to prescription-grade fish oil means higher profits and its R&D for new medical applications. Companies including DSM, BASF, and Croda are creating clinical-grade omega-3 formulations focused on improving the bioavailability and the delivery of drugs.
This phenomenon is persuading suppliers to narrow down product ranges according to purity, concentration levels (85%+), and absorption efficacy. The fish oil that was before a generic supplement is now a serious targeted medical intervention.
Volatility in Wild-Catch Fisheries and Raw Material Sourcing
Wild-caught fish, especially the Peruvian and Chilean anchovies, are the major source of fish oil for the global fish oil market. The uncertain supply of raw materials caused by climate change, the effects of El Niño, and restricted fishing quotas has led to price fluctuations and subsequent problems within the supply chain.
The manufacturers are increasingly opting for diversified sourcing, by moving to other fish species (e.g., sardines, mackerel) and seafood processing by-product extraction. Companies like TASA and Omega Protein are refining their extraction methods to get the best results as well as to research into krill oil and algal omega-3 as additional sources of supply.
A supply chain WWTP is now paramount, companies are joining hands on the fishery partnerships, and are also engaging cold storage logistics to keep levels stable. The sustainability-certified fish oil sources are also becoming more popular, and they ensure adherence to global fisheries laws.
Rising Demand from Aquaculture and Livestock Nutrition
The aquaculture industry is one of the main sanctions of fish oil, especially in the case of the salmon and shrimp farming industries, as there is a big demand for fish oil-rich EPA and DHA which increases growth and immune system health in fishes. With the growth of the global seafood market, fish farmers are starting to use more and more nutrient-rich feed formulations for the quality and productivity of fish.
This has caused an increase in competition on fish oil between the nutrition of humans and aquaculture sectors, which has led to the need for manufacturers to balance the supply. Innovative fish oil concentrates for feed applications are the area of focus for companies like Pelagia and GC Rieber VivoMega who provide exclusive ratios of EPA/DHA that are particular to each type of fish.
Furthermore, it has been noted that livestock nutrition uses omega-3 to improve the quality of milk and meat products, thus resulting in additional income. The central thought is to develop the high-stability fish oils that have longer shelf-life and hence less oxidation in the feed.
Regulatory Push for Heavy Metal and Contaminant-Free Products
Tighter rules and regulations on the heavy metals, dioxins, and PCBs are driving innovation and are changing the landscape of the fish oil market. Regulatory bodies such as the FDA, EFSA, and GOED have imposed stricter limits on the contaminants, which have consequently brought about the need for high-purity fish oil products.
As a move to deal with this, the manufacturers have turned to state-of-the-art technology such as molecular distillation, activated carbon filtration, and supercritical CO₂ extraction. The companies like Croda and Golden Omega have carved out a niche for themselves in the pharmaceutical-grade purification domain by providing low-toxin ultra-refined fish oils.
Now, the third-party certificates (IFOS, USP, and NSF) have become the key deciders in premium fish oil. Consumers are increasingly conscious of the purity aspect; hence manufacturers are also working on innovative packaging that is oxidation resistant, nitrogen-flushed softgels, and improved-shelf life formulations to uphold product integrity and fulfill the new safety standards.
Fish oil market worldwide is being ruled through two types of companies, which are large companies and specialized companies. The steady concentration level of the market lets the top companies hold a big part of the total market share.
The leading companies in the fish oil market across the globe include and involve some big names such as DSM (Netherlands), BASF SE (Germany), and Croda International Plc (UK). Their diverse variety of products and good international relations with wide-reaching and well-established distribution networks are the keys to their management retained dominance in the market.
Companies like GC Rieber VivoMega (Norway), Pelagia AS (Norway), and FF Skagen A/S (Denmark) follow only in the next line. These companies are mostly the ones who produce fish oil solely, they do this by mostly fishing in certain older areas, and of course, they have a culture of sustainability.Besides, they are famous for being trusted suppliers of responsibly sourced and well-processed fish oil.
The next group includes TASA (Peru), Omega Protein Corporation (USA), Copeinca ASA (Peru), and Golden Omega (Chile). They target very specific market niches such as promoting organic or sustainable fish oil production or they focus on specific end-user industries i.e. dietary supplements and pharmaceuticals. In general, the fish oil world market is moderately concentrated, with the first-rate multinationals gaining an important share of the market.
The mark the second and the third tier of the market, on the other hand, is more dynamic and competitive, with the players utilizing the regional advantages, the specialized product range, or the particular solutions that can meet the wide spectrum of food, and pharmaceuticals that use fish oil as a core ingredient these days.
The following table shows the estimated growth rates of the top three countries. USA, China and Norway are set to exhibit high consumption, and CAGRs of 3.8%, 6.3% and 2.5% respectively, through 2035.
| Countries | CAGR 2025 to 2035 |
|---|---|
| United States | 3.8% |
| China | 6.3% |
| Norway | 2.5% |
China has recently changed a lot in its fish oil industry, starting from the aquaculture model to high-value pharmaceutical applications. The fish oil market in China is being transformed through this process.
China is now becoming one of the top sources of pharmaceutical-grade omega-3 APIs (Active Pharmaceutical Ingredients) in the world as a result of its booming pharmaceutical industry and increasing prescription omega-3 drugs demand. Stand-out local companies like Fuyuan Aquatic, Xiamen Kingdomway, and Zhejiang NBT Marine Biopharmaceutical are heavily focusing on investing in high-purity EPA/DHA for medical applications.
Cardiovascular diseases are becoming a more serious health issue, therefore The National Medical Products Administration of China (NMPA) is intensifying omega-3 API quality regulations, which promote the companies to use more concentrated and refined fish oils.
Furthermore, Chinese businesses are developing capabilities to export high-purity fish oil to the drug manufacturers in Europe and North America. The trend of high-value fish oil products is shifting the psychology of the fish oil industry in China from aquaculture to pharmaceutical roles.
There is an explosion of high-efficiency omega-3 concentrates in the fish oil market in the USA thanks to the specification for personal EPA and DHA formulations that are in demand across clinical nutrition, functional foods, and premium supplements.
The fish oil producers who dominate the territory are like Omega Protein Corporation, DSM Nutritional Products (USA division), and Archer Daniels Midland (ADM), which are reshuffling the cards in the poker game of developing super-concentrated fish oils (≥85% EPA/DHA) powered by fractionation and molecular distillation systems. Consumers tend to search for omega-3 products which are more specific, such as formulas with increased EPA that benefit inflammation and heart health or high DHA that are aimed for brain health.
The bespoke subcriptions to supplement products being more in number and DTC owomega-3 formulations that only focus on potency, purity, and delivery formats are enough reasons this year for establishing this important trend in the USA fish oil market.
Salmon oil is now the market leader in the global fish oil industry with its unmatched omega-3 profile and bioavailability ranking it first in the choice of consumers. Unlike the common fish oils gotten from anchovies or sardines, salmon oil has the nutritiously balanced EPA and DHA that improves absorption, making it a gowild fresher choice among nutraceuticals, pharmaceuticals, and functional foods.
Salmon oils made from cold-pressed and molecularly distilled manufacturing processes by top-producing companies like GC Rieber VivoMega, Epax, and BASF aim to ensure a high level of purity and oxidation stability. Knowing the health benefits they provide, such as the absence of omega-3 the human brain, and the fight against chronic diseases, salmon oil producers are targeting a premium spot in the fish oil segment.
The global fish oil market is moderately consolidated, with established leaders like Omega Protein Corporation and TripleNine Group A/S holding strong positions through vertical integration, large-scale marine operations, and proprietary refining technologies. Omega Protein continues to expand its product portfolio by enhancing omega-3 concentration levels for the nutraceutical and pet food industries.
Meanwhile, TripleNine and FF Skagen are actively investing in sustainable sourcing and fish-byproduct valorization technologies. Pesquera Diamante and Corpesca S.A. are capitalizing on Peru’s strong anchovy landings, while Pesquera Exalmar focuses on boosting capacity and exports, especially to Asian markets.
Emerging players such as Marvesa Holding N.V. and Colpex International are gaining ground by entering niche markets like aquafeed and pharmaceutical-grade oils, often leveraging low-cost sourcing regions and innovative emulsification techniques.
Entry barriers include stringent sustainability standards (e.g., MSC certification), volatile raw material availability, and high capital investments in refinery and cold storage infrastructure. Overall, the industry is gradually leaning toward consolidation, driven by supply-chain control and technological differentiation.
Recent Fish Oil Industry News
Feed Grade, Food Grade, Pharma Grade
Salmon Oil, Tuna Oil, Cod Liver Oil, Sardine Oil, Squalene Oil, Krill Oil, Anchovy Oil, Menhaden Oil and Others
Crude Fish Oil, Refined Fish Oil, Modified Fish Oil
Aqua-Feed, Food and Beverages, Dietary Supplements, Cosmetic and Beauty Products
Industry analysis has been carried out in key countries of North America, Latin America, Europe, Middle East and Africa, East Asia, South Asia, and Oceania
Within the Forecast Period, the market is expected to grow at a CAGR of 9%.
By 2035, the sales value of the industry is expected to reach USD 24.6 billion.
Explore Similar Insights
Fish Oil Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
